Previous 10 | Next 10 |
Extremely poor, mostly high negative return since LABU’s inception. 3X derivative investments are extremely volatile and risky, and invite higher expense ratios. LABU’s benchmark index made losses in more number of days than it made gains, a trend which may continue ...
CURE is one of those rare 3x ETFs which generated positive returns under every scenario. In six out of the past ten years, CURE has recorded unprecedented growth ranging from 50 percent to 165 percent. Being a 3x ETF with negligible dividend yield and high expense ratio, CURE is a...
3X inverse derivative investments are extremely volatile and risky. Higher fees result in significant losses over a long-term horizon. Extremely poor, mostly high negative return since its inception in 2015. For further details see: LABD: 3X Leveraged Investments Not Sui...
Leveraged ETFs behavior is neither intuitive nor predictable. A dashboard with 20+ of them. Historical decay of SDS is close to zero on average, but it may hurt on limited periods of time. For further details see: SDS And Leveraged ETFs: March Drift Dashboard
A drift dashboard with 24 leveraged ETFs. Some silver and semiconductor leveraged ETFs recently suffered significant decay. Historical study of SPXU drift. For further details see: SPXU And Leveraged ETFs Drift In February
Gainers: S&P Biotech Bull 3X Direxion (NYSEARCA:LABU) +22%. Direxion Travel & Vacation Bull 2X ETF (NYSEARCA:OOTO) +21%. Semiconductor Bull 3X Direxion (NYSEARCA:SOXL) +14%. Physical Palladium ETF (NYSEARCA:PALL) +13%. Ultrapro Russell 2000 ETF (NYSEARCA:URTY) ...
The Premium Portfolio has gained +6.80% YTD compared to the S&P 500 +21.62% YTD and the Aurum Hedge Fund Industry Index +6.31% with one week to go. The Premium Portfolio compound annual growth rate (CAGR) of +25.57% compares favorably to the S&P 500 of +14.31% CAGR from 2018. ...
Gainers: FTSE China Bear 3X Direxion (NYSEARCA:YANG) +18%. S&P Oil & Gas Expl Bear 3X Direxion (NYSEARCA:DRIP) +17%. Microsectors -3X U.S. Big Oil Index ETN (NYSEARCA:NRGD) +15%. S&P Biotech Bull 3X Direxion (NYSEARCA:LABU) +15%. Microsectors Fang+ -3X ETN (NYSEARCA:FNGD) +14%. Lo...
The biotechnology sector largely underperformed the broader market this year, particularly small- to mid-cap biotech indexes whose constituents tend to experience more volatility. Contributing factors to the market decline include fears of increased regulation and oversight of M&A...
Leveraged ETFs behavior is not intuitive. A dashboard with 20+ of them. A closer look at SDS. For further details see: Beware Of SDS: The Drift Dashboard
News, Short Squeeze, Breakout and More Instantly...
Direxion Daily S&P Biotech Bear 3X Shares Company Name:
LABD Stock Symbol:
NYSE Market:
2024-07-12 19:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-01 07:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-22 08:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...